The integrin αMβ2 anchors hematopoietic progenitors in the bone marrow during enforced mobilization

被引:36
作者
Hidalgo, A
Peired, AJ
Weiss, LA
Katayama, Y
Frenette, PS
机构
[1] CUNY Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA
[2] CUNY Mt Sinai Sch Med, Immunobiol Ctr, New York, NY 10029 USA
关键词
D O I
10.1182/blood-2003-10-3702
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The sulfated polysaccharide fucoidan can rapidly mobilize hematopoietic progenitor cells (HPCs) and long-term repopulating stem cells from the bone marrow (BM) to the circulation. While searching for mechanisms involved in this phenomenon we found that BM myeloid cells bound to fucoidan through the integrin alphaMbeta2(macrophage antigen-1 [Mac-1])and L-selectin resulting in alphaMbeta2-independent release of neutrophil elastase, but inhibition of elastase activity did not impair fucoidan-induced mobilization. Mobilization of HPCs by fucoidan was enhanced in animals deficient in alphaM (alphaM(-/-)) compared with wild-type (alphaM(+/+)) animals and higher plasma levels of the chemokine CXCL12/stromal cell-derived factor-1 (SDF-1) were achieved in alphaM(-/-) mice by fucoidan treatment. However, in chimeric animals harboring alphaM(+/+) and alphaM(-/-) HPCs in the BM, alphaM(-/-) HPCs were preferentially mobilized by fucoidan, suggesting that the enhanced mobilization is cell intrinsic and does not result from altered microenvironment. Suboptimal doses of granulocyte colony-stimulating factor (G-CSF) or cyclophosphamide (CY) also resulted in enhanced HPC mobilization in alphaM(-/-) mice compared with alphaM(+/+) controls, but this difference was overcome when standard doses of G-CSF or CY were administered. Taken together, these data suggest that the integrin alphaMbeta2 participates in the retention of HPCs in the BM. (C) 2004 by The American Society of Hematology.
引用
收藏
页码:993 / 1001
页数:9
相关论文
共 52 条
[1]   The chemokine SDF-1 is a chemoattractant for human CD34(+) hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34(+) progenitors to peripheral blood [J].
Aiuti, A ;
Webb, IJ ;
Bleul, C ;
Springer, T ;
GutierrezRamos, JC .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (01) :111-120
[2]   OLIGOSPECIFICITY OF THE CELLULAR ADHESION RECEPTOR MAC-1 ENCOMPASSES AN INDUCIBLE RECOGNITION SPECIFICITY FOR FIBRINOGEN [J].
ALTIERI, DC ;
BADER, R ;
MANNUCCI, PM ;
EDGINGTON, TS .
JOURNAL OF CELL BIOLOGY, 1988, 107 (05) :1893-1900
[3]  
ALTIERI DC, 1988, J BIOL CHEM, V263, P7007
[4]   ANTI-MAC-1 SELECTIVELY INHIBITS THE MOUSE AND HUMAN TYPE 3 COMPLEMENT RECEPTOR [J].
BELLER, DI ;
SPRINGER, TA ;
SCHREIBER, RD .
JOURNAL OF EXPERIMENTAL MEDICINE, 1982, 156 (04) :1000-1009
[5]   Human leukocyte elastase is an endogenous ligand for the integrin CR3 (CD11b/CD18, Mac-1, alpha(M)beta(2)) and modulates polymorphonuclear leukocyte adhesion [J].
Cai, TQ ;
Wright, SD .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (04) :1213-1223
[6]  
COOMBE DR, 1994, BLOOD, V84, P739
[7]   A novel role for the beta 2 integrin CD11b/CD18 in neutrophil apoptosis: A homeostatic mechanism in inflammation [J].
Coxon, A ;
Rieu, P ;
Barkalow, FJ ;
Askari, S ;
Sharpe, AH ;
vonAndrian, UH ;
Arnaout, MA ;
Mayadas, TN .
IMMUNITY, 1996, 5 (06) :653-666
[8]   THE I-DOMAIN IS A MAJOR RECOGNITION SITE ON THE LEUKOCYTE INTEGRIN MAC-1 (CD11B/CD18) FOR 4 DISTINCT ADHESION LIGANDS [J].
DIAMOND, MS ;
GARCIAAGUILAR, J ;
BICKFORD, JK ;
CORBI, AL ;
SPRINGER, TA .
JOURNAL OF CELL BIOLOGY, 1993, 120 (04) :1031-1043
[9]   ICAM-1 (CD54) - A COUNTER-RECEPTOR FOR MAC-1 (CD11B CD18) [J].
DIAMOND, MS ;
STAUNTON, DE ;
DEFOUGEROLLES, AR ;
STACKER, SA ;
GARCIAAGUILAR, J ;
HIBBS, ML ;
SPRINGER, TA .
JOURNAL OF CELL BIOLOGY, 1990, 111 (06) :3129-3139
[10]   HEPARIN IS AN ADHESIVE LIGAND FOR THE LEUKOCYTE INTEGRIN MAC-1 (CD11B/CD18) [J].
DIAMOND, MS ;
ALON, R ;
PARKOS, CA ;
QUINN, MT ;
SPRINGER, TA .
JOURNAL OF CELL BIOLOGY, 1995, 130 (06) :1473-1482